These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 27721250)

  • 1. Adjuvant therapy with heparin in patients with lung cancer without indication for anticoagulants: A systematic review of the literature with meta-analysis.
    Yu Y; Lv Q; Zhang B; Lan F; Dai Y
    J Cancer Res Ther; 2016 Oct; 12(Supplement):37-42. PubMed ID: 27721250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer.
    Akl EA; Kahale L; Sperati F; Neumann I; Labedi N; Terrenato I; Barba M; Sempos EV; Muti P; Cook D; Schünemann H
    Cochrane Database Syst Rev; 2014 Jun; (6):CD009447. PubMed ID: 24966161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation.
    Akl EA; van Doormaal FF; Barba M; Kamath G; Kim SY; Kuipers S; Middeldorp S; Yosuico V; Dickinson HO; Schünemann HJ
    Cochrane Database Syst Rev; 2007 Jul; (3):CD006652. PubMed ID: 17636846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis on anticoagulation and prevention of thrombosis and mortality among patients with lung cancer.
    Fuentes HE; Oramas DM; Paz LH; Casanegra AI; Mansfield AS; Tafur AJ
    Thromb Res; 2017 Jun; 154():28-34. PubMed ID: 28402864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation.
    Akl EA; Gunukula S; Barba M; Yosuico VE; van Doormaal FF; Kuipers S; Middeldorp S; Dickinson HO; Bryant A; Schünemann H
    Cochrane Database Syst Rev; 2011 Jan; (1):CD006652. PubMed ID: 21249680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low molecular weight heparin in treating patients with lung cancer received chemotherapy: A meta-analysis.
    Liu ZL; Wang Q; Wang M; Wang B; Huang LN
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S437-S443. PubMed ID: 29970703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and safety of low-molecular-weight heparin use for cancer treatment: a meta-analysis.
    Che DH; Cao JY; Shang LH; Man YC; Yu Y
    Eur J Intern Med; 2013 Jul; 24(5):433-9. PubMed ID: 23385011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation.
    Akl EA; Gunukula S; Barba M; Yosuico VE; van Doormaal FF; Kuipers S; Middeldorp S; Dickinson HO; Bryant A; Schünemann H
    Cochrane Database Syst Rev; 2011 Apr; (4):CD006652. PubMed ID: 21491396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-molecular-weight heparin vs unfractionated heparin for perioperative thromboprophylaxis in patients with cancer: a systematic review and meta-analysis.
    Akl EA; Terrenato I; Barba M; Sperati F; Sempos EV; Muti P; Cook DJ; Schünemann HJ
    Arch Intern Med; 2008 Jun; 168(12):1261-9. PubMed ID: 18574082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboprophylaxis for patients with cancer and central venous catheters: a systematic review and a meta-analysis.
    Akl EA; Kamath G; Yosuico V; Kim SY; Barba M; Sperati F; Cook DJ; Schünemann HJ
    Cancer; 2008 Jun; 112(11):2483-92. PubMed ID: 18404702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis.
    Sobieraj DM; Coleman CI; Tongbram V; Chen W; Colby J; Lee S; Kluger J; Makanji S; Ashaye A; White CM
    Pharmacotherapy; 2012 Sep; 32(9):799-808. PubMed ID: 22744711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of adjunctive anticoagulation in patients with lung cancer without indication for anticoagulants: a systematic review and meta-analysis.
    Zhang J; Zhang YL; Ma KX; Qu JM
    Thorax; 2013 May; 68(5):442-50. PubMed ID: 23321607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboprophylaxis in cancer patients with central venous catheters. A systematic review and meta-analysis.
    Chaukiyal P; Nautiyal A; Radhakrishnan S; Singh S; Navaneethan SD
    Thromb Haemost; 2008 Jan; 99(1):38-43. PubMed ID: 18217132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low molecular weight heparin (LMWH) for primary thrombo-prophylaxis in patients with solid malignancies - systematic review and meta-analysis.
    Ben-Aharon I; Stemmer SM; Leibovici L; Shpilberg O; Sulkes A; Gafter-Gvili A
    Acta Oncol; 2014 Sep; 53(9):1230-7. PubMed ID: 25162954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of heparin therapy for preventing venous thromboembolism in acute spinal cord injury.
    Liu Y; Xu H; Liu F; Lv Z; Kan S; Ning G; Feng S
    Int J Surg; 2017 Jul; 43():94-100. PubMed ID: 28579397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation in patients with cancer: an overview of reviews.
    Akl EA; Muti P; Schünemann HJ
    Pol Arch Med Wewn; 2008 Apr; 118(4):183-93. PubMed ID: 18575417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized phase III trial of low-molecular-weight heparin enoxaparin in addition to standard treatment in small-cell lung cancer: the RASTEN trial.
    Ek L; Gezelius E; Bergman B; Bendahl PO; Anderson H; Sundberg J; Wallberg M; Falkmer U; Verma S; Belting M;
    Ann Oncol; 2018 Feb; 29(2):398-404. PubMed ID: 29106448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboprophylaxis with low molecular weight heparin versus unfractionated heparin in intensive care patients: a systematic review with meta-analysis and trial sequential analysis.
    Beitland S; Sandven I; Kjærvik LK; Sandset PM; Sunde K; Eken T
    Intensive Care Med; 2015 Jul; 41(7):1209-19. PubMed ID: 25971389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer: a systematic review.
    Akl EA; Rohilla S; Barba M; Sperati F; Terrenato I; Muti P; Bdair F; Schünemann HJ
    Cancer; 2008 Oct; 113(7):1685-94. PubMed ID: 18720360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.